Adenoviral vectors for treating diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11488533

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Adenoviral vectors, including mutant adenoviruses, that have restriction sites in the E3 region, that facilitate its partial or total deletion, or select genes contained therein, and optionally compositions and methods for substituting heterologous gene(s) in the partially or totally deleted E3 region(s), which heterologous gene(s) being operably linked to endogenous adenoviral transcriptional control sequences will exhibit an expression pattern, both in terms of timing and degree of expression, similar to the endogenous adenoviral gene(s) that it replaces, and further optionally including mutations in other parts of the adenoviral genome, including certain E1B or E1A regions, and that have applications for diagnosing or treating disease, preferably disease involving unwanted cell growth, including cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONYX PHARMACEUTICALSRICHMOND CA 94806-5206

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hawkins, Lynda K Germantown, MD 5 42
Hermiston, Terry Corte Madera, CA 52 309
Johnson, Leisa Richmond, CA 10 156

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation